Serum- and HDL3-serum amyloid A and HDL3-LCAT activity are influenced by increased CVD-burden


Autoria(s): McEneny, Jane; McKavanagh, Peter; York, Edmund; Nadeem, Nida; Harbinson, Mark; Stevenson, Michael; Ball, Peter; Lusk, Lisa; Trinick, Thomas; Young, Ian S; McKay, Gareth J; Donnelly, Patrick M
Data(s)

01/01/2016

31/12/1969

Resumo

<p>BACKGROUND: High density lipoproteins (HDL) protect against cardiovascular disease (CVD). However, increased serum amyloid-A (SAA) related inflammation may negate this property. This study investigated if SAA was related to CVD-burden.</p><p>METHODS: Subjects referred to the rapid chest pain clinic (n = 240) had atherosclerotic burden assessed by cardiac computerised tomography angiography. Subjects were classified as: no-CVD (n = 106), non-obstructive-CVD, stenosis<50% (n = 58) or moderate/significant-CVD, stenosis ≥50% (n = 76). HDL was subfractionated into HDL2 and HDL3 by rapid-ultracentrifugation. SAA-concentration was measured by ELISA and lecithin cholesterol acyltransferase (LCAT) activity measured by a fluorimetric assay.</p><p>RESULTS: We illustrated that serum-SAA and HDL3-SAA-concentration were higher and HDL3-LCAT-activity lower in the moderate/significant-CVD-group, compared to the no-CVD and non-obstructive-CVD-groups (percent differences: serum-SAA, +33% & +30%: HDL3-SAA, +65% and +39%: HDL3-LCAT, -6% & -3%; p < 0.05 for all comparisons). We also identified a positive correlation between serum-SAA and HDL3-SAA (r = 0.698; p < 0.001) and a negative correlation between HDL3-SAA and HDL3-LCAT-activity (r = -0.295; p = 0.003), while CVD-burden positively correlated with serum-SAA (r = 0.150; p < 0.05) and HDL3-SAA (r = 0.252; p < 0.001) and negatively correlated with HDL3-LCAT-activity (r = -0.182; p = 0.006). Additionally, multivariate regression analysis adjusted for age, gender, CRP and serum-SAA illustrated that HDL3-SAA was significantly associated with modifying CVD-risk of moderate/significant CVD-risk (p < 0.05).</p><p>CONCLUSION: This study has demonstrated increased SAA-related inflammation in subjects with moderate/significant CVD-burden, which appeared to impact on the antiatherogenic potential of HDL. We suggest that SAA may be a useful biomarker to illustrate increased CVD-burden, although this requires further investigation.</p>

Identificador

http://pure.qub.ac.uk/portal/en/publications/serum-and-hdl3serum-amyloid-a-and-hdl3lcat-activity-are-influenced-by-increased-cvdburden(68557620-8946-404d-98db-9786f14cc8c8).html

http://dx.doi.org/10.1016/j.atherosclerosis.2015.11.018

Idioma(s)

eng

Direitos

info:eu-repo/semantics/embargoedAccess

Fonte

McEneny , J , McKavanagh , P , York , E , Nadeem , N , Harbinson , M , Stevenson , M , Ball , P , Lusk , L , Trinick , T , Young , I S , McKay , G J & Donnelly , P M 2016 , ' Serum- and HDL3-serum amyloid A and HDL3-LCAT activity are influenced by increased CVD-burden ' Atherosclerosis , vol 244 , pp. 172-178 . DOI: 10.1016/j.atherosclerosis.2015.11.018

Tipo

article